Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Absolutely!! The stock was trading around $0.008 and testing a penny back in June before the CE came on. If there was no CE when they became fully reporting in Sept; this would be over $0.02 now and climbing.
You can't fault low volume and low share price when it's almost impossible to buy shares. Every brokerage makes selling (and shorting) easy. But only T Rowe Price is allowing anyone to create positions. As long as the average person can't buy stock in the open market - this will never see true valuations.
My prediction: in the next few months they should get the CE off and (hopefully) get rid of the SEC lawsuit. With open buying, we'll easily see $0.03 +. If they actually get the MS studies registered and started - it could be a LOT higher.
JMHO- GLTYA
A tweet - - - AND - - - - an SEC filing!! Ahead of the filing deadline!!
They are clearly working to stay current and not backslide. If they can just get the CE off the symbol - this could really run!!!
JMHO
QUARTERLY REPORT FILED EARLY !!!
They are staying on top of this:
NPHC 3Q2021
They told me 50,000 shares per trade. Sucks.
Exactly!!!
The SEC suit is BS - a civil suit seeking monetary damages that's already been partially dismissed.
This lawsuit is already baked into the stock valuation and won't mean anything once the CE comes off and the company starts releasing timely news.
Another week or two and we're off. UP UP UP!!!
The stock wasn't "stagnant". This was trading tens of millions of shares daily and back around a penny when the OTC Markets put on the CE. That destroyed the momentum and sent NPHC all the back to the trips for a hot second.
But this company has legs. Whoever can buy should be buying. The CE will be off soon and once everyone can buy again - we should see some real valuation. I predict this goes over a penny in the first two days of trading with the CE off.
JMHO - GLTYA
The company answered this a hundred times:
The CE went on because of promotional activity from a third party. The OTC Markets viewed the promotional activity ALONG WITH the delinquent filings as a "buyer beware" situation. Now that the filings are current and the promotional activity has ceased, the CE should come off soon.
Fully current. Get the CE gone and we're OFF!!!!!
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001119643/000149315221023540/form10-q.htm
Where are the guys that were shouting over the last few weeks - - - "not getting current" - - - - "heading to the trips" ?!?!
This will be current TOMORROW!!! The CE will be off soon and EVERYONE will start buying this up.
carolinatiger had an email from the company that talked about "coming out swinging" once they were current. SWING AWAY!!!!
What makes a debt "toxic" is usually a floating conversion price that's at a huge discount to market.
Funds like: Asher, JMJ, etc... loan money to a public company and can convert after 6 months - usually with a 50% discount to a lookback (the lowest price in the last 20 days or so). That usually amounts to getting the stock at half price or better. They convert a portion of the note and then they sell into the market without regard for crashing the price - because they already have at least a 50% margin to play with. After that - they convert again at an even lower price for even more shares - rinse and repeat.
This drives the stock price down and results in huge dilution.
NPHC announced last year that they no longer have any institutional "toxic" debt holders.
Orphan "Designation" never expires once it is so designated.
I think the confusion is that once the drug actually gets approved - the company gets seven years of exclusivity for the disease. But that's ONLY after drug approval.
Nutra Pharma's Orphan Designation for RPI-78M for the treatment of pediatric MS will never expire.
What do you mean "Orphan drug status is about to expire"?
Can you prove that or are you just making stuff up?
As far as I know - once something is designated as having Orphan Status - that is permanent and just needs the company to update the FDA center for orphan drugs on any progress. If the drug actually gets approved - then it gets all sorts of protections as an orphan drug.
The great thing about this Board is that it's full of successful Biotech CEOs. Just read their posts and see that ALL of them must run highly successful biotech companies and know exactly what the management of Nutra Pharma is going through. They know what it takes to get a Orphan Designation on a drug and to file and receive over 20 patents and to launch several highly effective OTC products - - - - they MUST know all of this by how they talk.
LOL
I don't listen to armchair quarterbacks - I know that the management of NPHC is fighting every day for their company and their shareholders. They have life-changing products that will become incredibly successful with market exposure and amazing drugs that will change lives around the globe. They just need a little time. When it finally happens - most of the world will say, "WOW - That Nutra Pharma was an overnight success story" - not knowing that it took years to get all of these pieces in place to finally break out.
THIS IS HAPPENING!!!!
You should go back and listen to the interview that Rik did a few months ago:
NPHC closed at $0.0031 on Friday - up 25% for the day. How can you honestly state: "steadily going down" ?!?!?
NPHC is now at $0.0022 x $0.0033 with CDEL at $0.0035. This will probably close at $0.0035; which would be up another 13%.
Of course - this is nothing compared to what will happen next week - after NPHC is current and the CE comes off.. . . . . .
LMAO - you need to stop trying to sell your "heading to the trips" line.
The shorting tried to crash the stock and it's already bounced back up - - - even before we can all buy on the wider market. Since only foreign buyers can purchase - the only domestic activity is market makers. They are desperate to keep the PPS down to prevent a run and eventual squeeze.
Some advice to the MMs - cover now - the squeeze is coming!!
Any activity now is artificial because all of us longs on the Board CAN'T BUY RIGHT NOW!!!
We would all be buying at these ridiculously low prices if we could. A little red or a little green means nothing right now until the CE comes off and we can see real volume return to the stock.
Regardless - I still think that we'll see some incremental growth as Canadians and Europeans still seem to be able to buy. I was also told that you can still purchase if you have a T. Rowe Price account. If anyone out there has a T. Rowe Price account - let me know if you can still get orders filled.
Thanks!
If the SEC had ever been serious about this case they would have:
- halted trading (didn't happen)
- referred to FBI for criminal acts (didn't happen)
- Would have been in a hurry to get this to court (now 3 years of this BS)
The SEC was hoping for a quick settlement or that the company would not have been able to afford to put up a fight. Historically, when companies and individuals go all the way to trial - they either beat the SEC or, even if there is a judgement against them, the court ordered penalties are MUCH lower than the SEC was seeking or offered in settlement.
Here's an older article that outlines some of these issues:
https://www.complianceweek.com/when-the-sec-charges-should-you-fight-or-settle/7001.article
Another article showing win/loss with the SEC:
https://www.corporatedefensedisputes.com/2016/08/who-wins-in-sec-administrative-proceedings/
This was always a BS civil case looking for a quick payout that didn't happen. There has already been a partial dismissal - - - which NEVER happens in a regulatory case and demonstrates some of the weaknesses in the SEC case.
Regardless - - ALL of the negatives of the SEC case are already baked into the valuation of NPHC stock. ANY positive news, outcome or even a structured settlement would only support much higher valuations!
UP UP UP UP - GO NPHC!!!
Yup.
First quarter of 2021 just dropped: https://www.sec.gov/Archives/edgar/data/0001119643/000149315221022993/form10-q.htm
One more filing - this thing is current - the skull and crossbones comes off and UP UP UP UP UP UP!!!!
Sorry - getting giddy :)
JMHO - GLTYA
Finally saw some green today!!
I'm trying to set up a T.Rowe Price account to get some of these cheapies!!
Wish me luck!
LOL - Posters keep talking about the company being "2 years behind" and then someone just said "four years behind" - this is just not true.
They filed 3Q 2018 in November of 2019. They filed the 2018 annual report in February of 2021. So - the furthest behind that the company EVER was - was 2 years and 3 months. Since then - as they filed more reports - they have been closer and closer to current. Now there's only 2 quarters to get fully current. SO close - - - I can taste it.
My biggest reason for being upset right now is that I can't buy the stock!!!
I would LOVE to cost average down right now, but none of my accounts will allow me to place orders with the CE on the symbol. I just spoke to T. Rowe Price and they will accept orders for NPHC. I'll open an account today, but it could be 2-3 days to be able to trade. If anyone out there has a T. Rowe Price account - let me know if you can place orders.
10K for 2020 filed:
https://www.sec.gov/Archives/edgar/data/0001119643/000149315221022204/form10-k.htm
The good stuff keep coming!! GO NPHC!!
Blah - - - - blah blah blah blah, Deitsch.
Blah - blah blah blah blah, SEC.
Blah, Multiple Sclerosis!?!?! Blah, orphan designation?!?! Blah, products that actually work!?!?!
Blah, still up over 20 times off of their lows. . . . .
I'm way up and still very happy with the prospects. The CE only came about because of promotional activity along with the filings delinquency. Once they're current - it comes off. And, by the way, the CEO explained the filing delinquency in several interviews: they had to pay for their legal defense from what he publicly stated was a frivolous suit from the SEC (that's already been partially dismissed). Now they've filed 8 of their missing reports with only three more left to go. It's getting done and then I expect to hear some very good things from the company.
GO NPHC, UP UP UP.
JMHO, GLTYA
I emailed Rik and this was his reply:
You guys really have no idea what's going on at the company. None of us do.
I can only go by the facts: NPHC has spent a lot of time and a lot of money getting the financials done. They've filed eight financials this year. They only have three left to get current. it would make absolutely no sense not to get it done ASAP.
The CE is ONLY on the symbol because of the promotion and the bullhorn last month. Before the bullhorn, the company was MUCH further behind in filings than previously - the promotional activity; added to the delinquent filings - was enough for the OTC Markets to state "Buyer Beware". Once they get current, the CE will come off and then we can see much better and more orderly trading. Just a few more weeks - you need to be patient and realize that this is a company with AMAZING products and AMAZING technology - that is just getting started to impress the world.
JMHO- GLTYA
This isn't "coming down to the wire" - NPHC is already compliant under the new SEC 15(c)211 regulations. This is proven by the fact that the symbol has already been removed from TDs list of affected symbols.
The new 15(c)211 rules basically states that a broker cannot quote a security unless they are "current" in their reporting obligations. The tricky part is that the SEC defines "current" as '.. having financial data available within 12 months and three days of a quotation."
Since NPHC filed their 3rd quarter of 2020 - they are now within that timeframe and are considered "current" as far as the 15(c)211 rules are concerned.
The OTC Markets want them to be fully current to get the CE off the symbol. That should be soon based on the emails from the company. I'm hoping that the 2020 10K comes out today before the long weekend and then the last two quarterlies should be quick.
JMHO - GLTYA
What is the actual definition of "Current"?
Everyone has been freaking out about the company getting fully current in their reporting obligations and pointing to the SEC changes to 15(c)211 as a warning that we can no longer trade in NPHC if they are not current.
That's not really what the rules say. in fact, the definition of current could mean that they published financials within 12-16 month of a broker quotation.
See: https://norrismclaughlin.com/blb/2020/10/29/securities-disclosures-pink-amendments-sec-rule-15c-11/
The quote from this article that got me:
"The amended Rule spells out revised financial information requirements in order to be “current.” A market professional may publish a quotation regarding a security, if a publicly available balance sheet is dated within 16 months of the quotation, as well as profit and loss and retained earnings statements for the 12 months preceding the date of the balance sheet."
If this is true, then the company is already current. I'm not saying that they shouldn't finish the job and get up to fully reporting status. Let's get the CE and Stop sign off the symbol. But I don't think that we need to worry about 15(c)211 issues.
JMHO - GLTYA
This next filing is a 10K for 2020 - - - a MUCH bigger deal than the last three quarterlies. This is fully audited - not just "reviewed" - so it's going to take a little longer. The good thing is that we just saw NPHC come out with quarterlies a week apart. So we know that after this 10K is dropped - it will be within 2 weeks to get the first two quarters filed.
My guess is the 10K comes out early next week and they're current by September 13th.
JMHO
The tweet about Amazon is awesome -
"#glitchfixed"
The Amazon stuff had nothing to do with the products or NPHC - it was an Amazon glitch that's been corrected. I was still buying my Nyloxin at www.Nyloxin.com - but it was annoying that some posters used the Amazon glitch as an attack on the company.
GO NPHC!!!!
Another filing done!!!
$NPHC Fulfilling on our commitment: We just filed another quarterly report - our auditors are doing concurrent reviews of the remaining reports. As promised, we are working diligently and doing everything in our power to get current as fast as possible! #MS #Nyloxin
— Nutra Pharma (@nutrapharma) August 5, 2021
It is annoying that this is being blatantly manipulated downward. If the shorters just left this one alone - we'd be trading through the roof right now - - but they keep re-setting their short positions everytime they see a weakness in the volume.
This should be illegal.
In the meantime - the PR today was AWESOME!!! They're lining everything up:
(1) hire IP attorneys
(2) hire DC lobbyists
(3) file new patents
- - - - have stuff to sell to the government with the protection it needs!!
Up Up UP - - JMHO, GLTYA
We'll see.
Kind of curious about the definition of "current". From what I've seen - it looks like NPHC could be "current" for the purpose of brokers quoting their stock as long as their filings are within 12 months of the quotation. So they would only need to get the 3rd quarter of 2020 done to be current on August 13th.
I think that is VERY doable - especially after the tweets about their auditors adding staff for review and doing concurrent reviews of the outstanding quarters.
NPHC had a rough week and an attack on Thursday and we finished about even for the week but a strong, green close. i look at all of his as a victory with some new heights shortly.
Up Up Up - - - JMHO, GLTYA
I got lucky today and added in the 4s.
As I've said before - Nyloxin has changed my life. NPHC makes GREAT products that have the potential to help MILLIONS of people. The roller coaster ride is painful to those of us that have been around for the last ten years or so - but it's worth the ride.
Prediction:
- get current
- announce deal with the US government for their nerve agent stuff
- announce clinical trials for their MS drug
- announce huge product sales into retail
- etc
- etc
- etc
There's WAAAYYY too much here to not see the potential.
We may have a few more weeks of roller coasting - but once they are current - - - TO THE MOON!!!
JMHO - GLTYA
Old news.
The company and Deitsch have already said that the auditors signed an agreement to get everything done in 2020, but the financials were, "much more complex than anticipated" and it's taken a lot longer.
Ric even talked about it in his online interview a few months ago. The auditors keep making and breaking their timelines.
The simple fact is - - the filings are getting done. It's slower than ANY of us wanted, but they are getting done. Another 10K out today and carolinatiger has a recent email from the Company that talked about most of 2020 already being worked on.
It's hilarious how some people try to turn a HUGE positive into a negative.
Getting a lawsuit off the books is GREAT.
There's NO WAY that it's anything but positive news. The short sellers are quaking in their boots!!